Skip to main content
Clinical Trials/NCT01344785
NCT01344785CompletedNot Applicable

The Effect of Loss of Offset After Pertrochanteric Fracture Treated With a Intramedullary Nail

Danderyd Hospital1 site in 1 country100 target enrollmentStarted: April 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Hip function

Study Overview

Brief Summary

The purpose of this study is determine the relationship between pain and protrusion of the implant after surgery for a intertrochanteric fracture.

Detailed Description

Intertrochanteric fractures are common fractures in which severe complications such as non-union, implant cut-out and postoperative wound-infections occur at very low rates with modern surgical techniques. While severe complications are rare, the patient reported outcome is less satisfactory with roughly half of the patients complain of thigh pain and others failing to regain their walking ability. The current leading methods for osteosynthesis of intertrochanteric fractures are intramedullary (IM) nails and sliding hip screws (SHS).

Over the period 1998 to 2007 the use of IM nails for pertrochanteric fractures increased from 5% to 20% in Sweden, at the expense of the use of SHS (5). IM nailing has also become more common at our clinic where we since February 2008 use the 3rd generation of the Gamma nail. In this study we investigate if the increased pain after IM nailing, reduced hip function and life quality may correlate to the compression over the fracture and the lateral protrusion of the intramedullary nail.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
55 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Intertrochanteric Fracture
  • Age over 55
  • Intramedullary nailing

Exclusion Criteria

  • Severe cognitive impairment
  • Substance abuse

Outcomes

Primary Outcomes

Hip function

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Danderyd Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olof Skoldenberg

Consultant Orthopaedic surgeon

Danderyd Hospital

Study Sites (1)

Loading locations...

Similar Trials